Deerfield Private Design Fund III, L.P. Insider Trading -- Recent SEC Form 4 Transactions

Deerfield Private Design Fund III, L.P. (CIK 1603333) reported 17 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-06-11). Recent activity: Buy PBLS (122,990 shares), Buy PBLS (122,990 shares), Buy PBLS (149,238 shares), Buy PBLS (149,238 shares), Buy PBLS (260,992 shares). Source: SEC Form 4.

DateCompanyRoleTypeSharesValue
2026-06-11Parabilis Medicines, Inc. (PBLS)InsiderBuy122,990$0
2026-06-11Parabilis Medicines, Inc. (PBLS)InsiderBuy122,990$0
2026-06-11Parabilis Medicines, Inc. (PBLS)InsiderBuy149,238$0
2026-06-11Parabilis Medicines, Inc. (PBLS)InsiderBuy149,238$0
2026-06-11Parabilis Medicines, Inc. (PBLS)InsiderBuy260,992$0
2026-06-11Parabilis Medicines, Inc. (PBLS)InsiderBuy260,992$0
2026-06-11Parabilis Medicines, Inc. (PBLS)InsiderBuy407,132$0
2026-06-11Parabilis Medicines, Inc. (PBLS)InsiderBuy407,132$0
2026-03-02Larimar Therapeutics, Inc. (LRMR)DirectorBuy1.1M$5.4M
2026-03-02Larimar Therapeutics, Inc. (LRMR)DirectorBuy1.1M$5.4M
2026-03-02Larimar Therapeutics, Inc. (LRMR)DirectorBuy831,978$4.2M
2026-03-02Larimar Therapeutics, Inc. (LRMR)DirectorBuy2.0M$10.0M
2025-08-04Larimar Therapeutics, Inc. (LRMR)DirectorBuy3.4M$10.8M
2025-08-04Larimar Therapeutics, Inc. (LRMR)DirectorBuy3.4M$10.8M
2025-08-04Larimar Therapeutics, Inc. (LRMR)DirectorBuy2.6M$8.3M
2025-07-01ARS Pharmaceuticals, Inc. (SPRY)InsiderSell370,075$6.8M
2025-07-01ARS Pharmaceuticals, Inc. (SPRY)InsiderSell370,074$6.8M

Source: SEC Form 4 filings · as of 2026-06-11